Feedback / Questions
QTX3034 - Quanta Therap
https://www.globenewswire.com/news-release/2025/10/24/3172963/0/en/Quanta-Therapeutics-Presents-Positive-Phase-1-Data-for-QTX3034-an-Oral-G12D-Preferring-Multi-KRAS-Inhibitor-in-Patients-with-Advanced-Solid-Tumors.html
Oct 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next